17 research outputs found
Is material human immunodeficiency virus positivity a risk factor for the development of necrotizing enterocolitis in premature infants
A research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, in partial fulfillment of the requirements for the degree of Master of Medicine in the Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand.
Johannesburg, 2015Introduction
Little is known about the association between maternal HIV status and the development of necrotizing enterocolitis (NEC) in premature infants. The few studies that have been published give no clear picture. In the light of the high maternal HIV infection in South Africa, it is important to explore the association between maternal HIV infection and all aspects of the paediatric population.
Objectives
The primary objective of this study was to determine if maternal HIV positive status was associated with the development of NEC in preterm infants who were born in one of our academic hospitals.
The second objective was to determine the severity, need for surgery and mortality of preterm infants with NEC according to maternal HIV status.
Finally, the third objective was to determine risk factors associated with NEC.
Method
The study population included preterm newborns less than 1500 grams born at the CMJAH and admitted to the neonatal unit within 24 hours of birth. Data on maternal and infant characteristics were collected from the computerized neonatal database from January 2006 to December 2013.
Results
A total of 2355 infants <1500g constituted the study population. Of these 126 met the inclusion criteria for NEC and 2229 did not. Therefore, large proportions were not entered for a multivariate analysis.
Univariate analysis did not demonstrate an association between maternal HIV positive status and NEC (OR: 1.3, 95% CI: 0.8-1.9, p= 0.2). Therefore it was not entered into the multivariate analysis.
On multivariate analysis antenatal corticosteroids showed a protective association with NEC (OR: 0.2, 95% CI: 0.1-0.4, p< 0.05). Multiple pregnancy and the need for resuscitation at birth was associated with NEC (OR: 1.6, 95% CI: 1-2.5, p= 0.03), (OR: 8, 95% CI: 4.5-15, p< 0.05), respectively.
The analysis also found that severity of NEC, the need for surgery and mortality among infants with NEC did not differ according to maternal HIV status (p= 0.9, p=0.7 and p= 0.4), respectively.
Conclusions
The analysis was not able to demonstrate an association between maternal HIV positivity and the risk of NEC. Risk factors for NEC that were identified were multiple pregnancies and the need for resuscitation at birth. Antenatal corticosteroids were found to have a protective association with NEC.
Finally, severity, need for surgery and mortality did not also differ according to maternal HIV status among the NEC group.MT201
Incidence and All-Cause Mortality Rates in Neonates Infected With Carbapenem Resistant Organisms
INTRODUCTION: Multidrug-resistant, Gram-negative infections, particularly due to carbapenem resistant organisms (CRO), have increased globally. Few studies have reported on the burden of CRO in neonates from low-middle income countries (LMIC). This study aimed to determine the incidence and mortality rates of culture-confirmed Gram-negative infections, with a special focus on CRO in a neonatal unit from a LMIC. MATERIALS AND METHODS: Positive bacterial cultures from sterile sites of infants admitted in the neonatal unit from the 1st January 2018 to 31st December 2019, were reviewed retrospectively. Type of organism, susceptibility and outcomes were recorded. Data on Gram-negative isolates, including the CRO, were extracted. Rates and outcomes were analysed. RESULTS: There were 2219 neonates with organisms isolated from sterile sites (blood and cerebrospinal fluid), accounting for 30% of all admissions, giving a neonatal sepsis incidence of 17.9/1000 patient-days. There was a total of 1746 positive isolates (excluding coagulase negative Staphyloccocus). Of these, 1706 (98%) were isolated from blood, and 40 (2%) from cerebrospinal fluid. Overall, 1188 (68%) were Gram-negative, 371 (21%) Gram-positive and 187 (10.7%) fungal isolates. The common Gram-negatives were Acinetobacter baumannii (526/1188;44%) and Klebsiella pneumoniae (469/1188;40%). Carbapenem resistance was observed in 359 (68%) of the Acinetobacter baumannii (CRAB) and in 103 (18%) of the Enterobacterales (CRE) isolates, with 98% of CRE being Klebsiella pneumoniae (CR-Klebs). Twenty-four (41%) of Pseudomonas species were carbapenem resistant. Overall, carbapenem resistance was seen in 42% of all Gram-negative organisms. The rate of CRAB and CRE were 2.9 and 0.8/1000 patient-days respectively. The overall, all-cause in-hospital mortality rate in infants with Gram-negative isolates was 22%, with higher mortality rate in those infected with CRO compared to non-CRO (34% vs 13%; OR 3.44; 95% CI 2.58–4.60; p < 0.001). The mortality rate in infants with CRE was higher than those with CRAB (48% vs 33%; OR 1.85; 95% CI 1.18–2.89; p = 0.007). CONCLUSION: We observed a high incidence of positive cultures from sterile sites. The common organisms isolated were Gram-negatives, and among these carbapenem resistance was high and was associated with high mortality. Mortality was higher in infants with CRE compared to those with CRAB
Characteristics and outcomes of neonates with intrapartum asphyxia managed with therapeutic hypothermia in a public tertiary hospital in South Africa
AVAILABILITY OF DATA AND MATERIALS : The datasets used and/or analyzed during the current study are available from
the corresponding author on reasonable request.BACKGROUND : In randomized clinical trials, therapeutic hypothermia (TH) has been shown to reduce death and/or
moderate-to-severe disability in neonates with hypoxic ischemic encephalopathy (HIE) in high-income countries,
while this has not consistently been the case in low-and middle-income countries (LMICs). Many studies reporting
on outcomes of neonates with HIE managed with TH are those conducted under controlled study conditions, and
few reporting in settings where this intervention is offered as part of standard of care, especially from LMICs. In this
study we report on short-term outcomes of neonates with moderate-to-severe HIE where TH was offered as part of
standard of care.
OBJECTIVE : To determine characteristics and mortality rate at hospital discharge in neonates with moderate-to-severe
HIE.
METHODS : Hospital records of neonates with intrapartum asphyxia were reviewed for clinical findings, management
with TH (cooled or non-cooled) and mortality at hospital discharge. Inclusion criteria were birthweight ≥ 1800 g, gestational
age ≥ 36 weeks and moderate-to-severe HIE. Comparisons were made between survivors and non–survivors
in cooled and/or non-cooled neonates.
RESULTS Intrapartum asphyxia was diagnosed in 856 neonates, with three having no recorded HIE status; 30%
(258/853) had mild HIE, and 595/853 (69%) with moderate-to-severe HIE. The overall incidence of intrapartum
asphyxia was 8.8/1000 live births. Of the 595 with moderate-to-severe HIE, three had no records on cooling and 67%
(399/592) were cooled. Amongst 193 non-cooled neonates, 126 (67%) had documented reasons for not being cooled
with common reasons being a moribund neonate (54.0%), equipment unavailability (11.1%), pulmonary hypertension
(9.5%), postnatal age > 6 h on admission (8.7%), and improvement in severity of encephalopathy (8.7%). Overall
mortality was 29.0%, being 17.0% and 53.4% in cooled and non-cooled infants respectively. On multivariate analysis,
the only factor associated with mortality was severe encephalopathy.
CONCLUSION : Overall mortality in neonates with moderate-to-severe HIE was 29.0% and 17.0% in those who were
cooled. Cooling was not offered to all neonates mainly because of severe clinical illness, equipment unavailability and
delayed presentation, making it difficult to assess overall impact of this intervention. Prospective clinical studies need
to be conducted in LMIC to further assess effect of TH in short and long-term outcomes.https://bmcpediatr.biomedcentral.comam2024ImmunologySDG-03:Good heatlh and well-bein
An outbreak of infection due to severe acute respiratory corona virus-2 in a neonatal unit from a low and middle income setting
IntroductionThe provision of kangaroo mother care (KMC) involving continuous skin-to-skin care (SSC) is an important intervention in neonatal care, which is recommended even when women are infected with severe acute respiratory syndrome coronavirus (SARS-CoV-2). We report on a nosocomial outbreak of SARS-CoV-2 infections in a KMC ward.MethodsContact tracing was conducted following the diagnosis of SARS-CoV-2 in a mother lodging in the KMC ward. All mother-newborn dyads in the KMC and healthcare workers (HCW) were tested for SARS-CoV-2 within 24–72 h of diagnosing the index case. Nasopharyngeal swab samples were obtained and tested from contacts, with a nucleic acid amplification test (NAAT) assay. Next-generation sequencing was done on positive samples. The secondary attack rate (SAR) was calculated assuming that the mother who presented with symptoms was the source of infection.ResultsTwelve (70.6%) of 17 mothers and 8 (42.1%) of 19 neonates who were in the KMC ward with the index case were found to be positive with SARS-CoV-2. Seven (87.5%) of the 8 neonates who tested positive had mothers who also tested positive. Seventy-five percent (9/12) of the mothers and 62.5% (5/8) of the neonates who tested positive were asymptomatic. Eight (27.6%) of 29 HCW were found to be positive and were all asymptomatic. One neonate died from Acinetobacter baumannii sepsis, and his post-mortem lung histopathology showed features compatible with SARS-CoV-2 pneumonia. The sequencing of 13 specimens, which included 1 mother-newborn dyad, indicated clustering to the same phylogenetic lineage with identical mutations. In assessing for factors contributing to this outbreak, it was found that spaces between beds were less than 1 m and mothers had their meals around the same table at the same time.ConclusionWe report on a nosocomial outbreak of SARS-CoV-2 in a KMC ward, affecting a high number of mothers and neonates, and to a lesser extent HCWs. Although it is difficult to point to the index case as the source of this outbreak, as asymptomatic individuals can spread infection, the inadequate adherence to non-pharmaceutical interventions was assessed to have contributed to the spread of infection. This highlights the need for awareness and adherence to mitigation strategies to avoid SARS-CoV-2 outbreaks
Neonatal invasive candidiasis in low-and-middle-income countries: data from the NeoOBS study
Neonatal invasive candidiasis (NIC) has significant morbidity and mortality. Reports have shown a different profile of those neonates affected with NIC and of fluconazole resistant Candida spp. isolates in low-and-middle-income -countries (LMICs) compared to high-income-countries (HIC). We describe the epidemiology, Candida spp. distribution, treatment and outcomes of neonates with NIC from LMICs enrolled in a global, prospective, longitudinal, observational cohort study (NeoOBS) of hospitalised infants < 60 days postnatal age with sepsis (August 2018-February 2021). 127 neonates from 14 hospitals in 8 countries with Candida spp. isolated from blood culture were included. Median gestational age of affected neonates was 30 weeks (IQR: 28-34) and median birth weight was 1270 g (IQR: 990-1692). Only a minority had high risk criteria, such as being born < 28 weeks, 19% (24/127), or birth weight < 1000 g, 27% (34/127). The most common Candida species were C. albicans (n = 45, 35%), C. parapsilosis (n = 38, 30%) and Candida auris (n = 18, 14%). The majority of C. albicans isolates were fluconazole susceptible, whereas 59% of C. parapsilosis isolates were fluconazole resistant. Amphotericin B was the most common antifungal used [74% (78/105)], followed by fluconazole [22% (23/105)]. Death by day 28 post-enrolment was 22% (28/127). To our knowledge, this is the largest multi-country cohort of NIC in LMICs. Most of the neonates would not have been considered at high risk for NIC in HICs. A substantial proportion of isolates was resistant to first choice fluconazole. Understanding the burden of NIC in LMIC is essential to guide future research and treatment guidelines
Proceedings of the 13th International Newborn Brain Conference: Neuroprotection strategies in the neonate
Incidence, pathogens and antimicrobial resistance of blood and cerebrospinal fluid isolates from a tertiary neonatal unit in South Africa: A 10 year retrospective review.
ObjectiveTo determine trends in incidence, etiology and antimicrobial susceptibility of blood and cerebrospinal fluid (CSF) culture confirmed infections in hospitalized infants in a large tertiary neonatal unit in South Africa.MethodsSingle-center, retrospective review of laboratory records of bacteria and fungi, and their susceptibility profiles, isolated from blood and CSF of infants hospitalized in the neonatal unit at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa, from 1st January 2010 to 31st December 2019. Laboratory data on isolates and their antimicrobial susceptibilities were collected. Coagulase-negative Staphylococcus, Corynebacteria and Bacillus spp. were excluded. Patient-level clinical and laboratory data were not available.ResultsThere were 8,319 significant isolates, giving an infection rate of 14.3/1000 patient-days. Infection rates increased from 12.0 to 15.7/1000 patient-days (estimated average yearly change 0.6[95%CI, 0.5-0.7];p = ConclusionsThere has been a marked overall increase in rates of blood and/or CSF infections, with an absolute increase in Gram-negative infections observed, replacing Gram-positive and fungal pathogens. Extended spectrum beta-lactamase Gram-negative isolates are being replaced by carbapenem resistance, with around one third of all significant Gram-negative isolates now carbapenem resistant. Research into hospital based novel treatment and prevention interventions for neonatal sepsis should be urgently prioritized
Bacterial isolates from blood and/or CSF, per year, from 2010 to 2019.
Bacterial isolates from blood and/or CSF, per year, from 2010 to 2019.</p
Proportion of <i>Staphylococcus aureus</i> isolates with methicillin resistance cultured from blood and/or CSF, from 2010 to 2019.
Proportion of Staphylococcus aureus isolates with methicillin resistance cultured from blood and/or CSF, from 2010 to 2019.</p
Annual number of isolates, live births, admissions and patient-days, and annual infection rates from 2010 to 2019.
Annual number of isolates, live births, admissions and patient-days, and annual infection rates from 2010 to 2019.</p